Advances to SYNTHIA™ Retrosynthesis Software and How They Have Accelerated Chemical Development at GlaxoSmithKline (GSK)

Available On Demand John Jin Lim, MS Senior ScientistAPI ChemistryGlaxoSmithKline plc (GSK) John Lim (MS) leads the CASD Team at GSK Chemical Development, which uses computational tools, such as SYNTHIA™ retrosynthesis software, for the route selection process. He obtained his Bachelor’s degree from the University of Pennsylvania, interning in the lab of Dr. Amos Smith,…

IL-13 is a Pathogenic Driver of COVID-19

Speaker Alexandra Donlan Graduate StudentUniversity of Virginia Alexandra received her bachelor’s degree in Biological Sciences from Florida State University, where she studied the role of exosomes in the oncogenesis of Epstein-Barr virus in the lab of Dr David Meckes. She is working towards her PhD at the University of Virginia with Dr Bill Petri and…

Analyte Binding Following Sample Filtration in HPLC

Speaker Vivek Joshi Senior R&D ManagerApplications DevelopmentMilliporeSigma Vivek Joshi, PhD is an Applications and Market Adoption Senior Manager at MilliporeSigma. He develops new products and applications for products that span analytical workflows, molecular and protein science workflows, and cell culture workflows. He recently presented a sample preparation module in the Drug Dissolution Training offered by…

The End of the Beginning for Retrosynthetic Planning

Significant advances in SYNTHIA™ opening doors for complex molecule synthesis and bench validation Lindsey Rickershauser, Ph.D. Manager of Sales & MarketingCheminformatics TechnologiesMerck KGaA, Darmstadt, Germany Lindsey Hess Rickershauser, PhD, currently manages the sales and marketing for SYNTHIA™ in the Cheminformatics Technologies division of MilliporeSigma, a business of Merck KGaA, Darmstadt, Germany. In 2010 she received…

Development of ultrasensitive immunoassays for SARS-CoV-2 antibody detection

Speaker Rosemary Sweetwood Manager, CAST Sample Testing, Scientist II CAST Custom Assay DevelopmentMilliporeSigma Rosemary Sweetwood has worked with SMC™ technology for over 7 years in diagnostic development, assay development, and custom manufacturing, as well as managing clinical sample testing projects for our SMC™ Sample Testing customers. With almost two decades of research experience working in…

IgG Antibodies Against SARS-CoV-2 Correlate to Days from Symptom Onset in COVID-19 Positive Patients

Speaker Mary Young Research TechnicianUniversity of Virginia, School of Medicine Mary Young has her Bachelors of Science in Biology from Elon University. She joined the Petri Lab 3 years ago as a research technician helping with several projects, mainly focusing on human immune response to Clostridioides difficile infection. When the pandemic hit Virginia in March,…

Immune Responses in Severe COVID-19 Patients

Speaker Professor Dexi Chen, the Director of the Beijing Institute of Hepatology, present data on immune responses in severe COVID-19.

Assay Development for Quantification of Low-abundance Proteins Using Single Molecule Counting

Assay Development for Quantification of Low-abundance Proteins Using Single Molecule Counting On-Demand Sponsored by Sarah Hamren MilliporeSigma In this tutorial you will find: How MilliporeSigma’s Single Molecule Counting (SMC™) platform can be used to detect even very low levels of Huntingtin protein How to reach fM levels of sensitivity detecting both mHTT and total HTT…

Assay Development for Quantification of Low-abundance Proteins Using Single Molecule Counting

Assay Development for Quantification of Low-abundance Proteins Using Single Molecule Counting In this tutorial, you will find: How MilliporeSigma’s Single Molecule Counting (SMC™) platform can be used to detect even very low levels of Huntingtin protein How to reach fM levels of sensitivity detecting both mHTT and total HTT Development and validation of High Sensitivity…